The Challenge of Change - Managing Excipients Control
Colorcon
12-Jul-2011 - in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at Merck Serono, Ascletis, Allon, Acura, Sangamo and ProStrakan.
12-Jul-2011 - Later today (July 12), at 4pm CEST to be precise, our sister website Outsourcing-pharma.com will launchOncologyTrialsOutsourcing – an industry first virtual conference – covering all aspects of third-party cancer drug development.
05-Jul-2011 - Onco Therapies Limited (OTL), a division of Aglia, a wholly owned subsidiary of Strides Arcolab Limited, has been given the go ahead from Europe for its Oral Dosage Oncology facility.
05-Jul-2011 - Shire has received European Medicines Agency (EMA) approval for a new US plant, doubling purification capacity for its Fabry disease drug Replagal.
30-Jun-2011 - in-Pharmatechnologist.com presents a round up of developments in the pharmaceutical manufacturing space with news from Dendreon, Amcor and Cody Labs.
30-Jun-2011 - Par Pharmaceutical will cut 100 jobs at its proprietary products division Strativa Pharmaceuticals as part of a restructuring plan designed to save as much as $12m.
29-Jun-2011 - US drug giant Pfizer has exercised its option to re-acquire a manufacturing facility in Rouses Point, New York from Akrimax.
29-Jun-2011 - in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at Soligenx, Arno Therapeutics, Euthymics and Aeris Therapeutics.
28-Jun-2011 - Sanofi Pasteur has opened a new centre in Canada in an effort to streamline its global vaccine R&D operations.
27-Jun-2011 - BioMarin will buy Pfizer’s biologics manufacturing plant in Shanbally, Cork, Ireland to add production capacity for its candidate mucopolysaccharidosis treatment.
27-Jun-2011 - The Pharmaceutical Research and Manufacturers of America (PhRMA) has welcomed proposed changes to US patent laws that would alter the basis for patent awards.
23-Jun-2011 - Social media can play a role in ensuring that medicines are safe, but regulatory input is needed according to the Drug Safety Alliance (DSA).
23-Jun-2011 - Watson Pharmaceuticals has initiated a $44m (€31m) expansion of its Utah R&D and manufacturing plant for transdermal patches and topical gels.
23-Jun-2011 - Novartis has started work on a manufacturing plant in St Petersburg in the first stage of a $500m investment in the Russian pharmaceutical industry.
20-Jun-2011 - Catalent Pharma Solutions and German expression system developer Cevec Pharmaceuticals have partnered to create a cell development service that, they claim, will help drugmakers generate stable lines faster.
20-Jun-2011 - Grindeks has opened a 2,300 sq m API production plant in Latvia that will boost UDCA sales to €10m ($14m) a year when at full capacity.
16-Jun-2011 - US drugmaker APP Pharmaceuticals will invest $38m to boost its manufacturing capacity for injectable generic drugs at its facility in Grand Island.
16-Jun-2011 - William Reed Business Media, publisher of In-PharmaTechnologist.com, has opened an office in Lower Manhattan, New York City to re-enforce its position as the leading provider of independent news serving the US and global pharmaceutical industries.
15-Jun-2011 - A new online adverse drug event (ADE) network will improve the quality of data and, ultimately, boost drugmakers’ cost-efficiencies according to developer PDR Network.
15-Jun-2011 - GlaxoSmithKline (GSK) is investing more than CA$30m (€21m) to add dermatology product manufacturing capabilities and create 70 jobs at a Canadian plant.
15-Jun-2011 - in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at PhRMA, Dyax, Alnylam, Avi BioPharma, Pacira, Asmacure and Xceleon.
14-Jun-2011 - GlaxoSmithKline (GSK) has announced plans to buy its joint venture Shenzhen GSK Neptunus Biologicals (GSKNB) to expand influenza vaccine production capacity in China.
09-Jun-2011 - Pfizer has begun what it claims is the world’s first ‘virtual’ trial and says that such innovation is needed to make sure clinical research is sustainable.
09-Jun-2011 - Drug maker Aurobindo Pharma has been cleared to make a generic equivalent of Pfizer’s CNS drug Xanax XR by the US FDA.
07-Jun-2011 - Indian drugmakers Serum Institute and Panacea Biotech have reduced what they charge the GAVI for vaccines, prompting similar commitments from several Big Pharma firm.